CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
01. Oktober 2024 07:00 ET
|
CytoSorbents
CytoSorbents files for FDA De Novo marketing approval of DrugSorb-ATR to reduce the severity of CABG-related bleeding due to the blood thinner ticagrelor
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
07. August 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Report Q2 2024 Financial and Operating Results
Myodyal Infarction Market Forecast to Reach $3.43 Billion by 2032: Global Analysis by Drug Class, Distribution Channel, Region and Company
20. Juni 2024 06:28 ET
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global Myocardial Infarction Market Report by Drug Class, Distribution Channels, Regions and Company Analysis 2024-2032" report has been added to ...
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
04. Juni 2024 07:00 ET
|
CytoSorbents
CTSO STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024
Blood Preparation Market Size, Share & Trends Analysis Report 2023- Global Forecast to 2030 Featuring Pfizer, Bristol-Myers Squibb, Leo Pharma, Sanofi, Xiamen Hisunny Chemical, AstraZeneca, Baxter
16. November 2023 07:28 ET
|
Research and Markets
Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And...
ESG Perspective: Sustainability Gains Importance in the Antithrombotic/Anticoagulant Drugs Market
02. November 2023 05:03 ET
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global...
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
27. September 2023 07:00 ET
|
CytoSorbents
CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress
Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
21. September 2023 09:58 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
07. Juli 2023 07:07 ET
|
CytoSorbents
PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood...
Insights on the $87+ Billion Cardiovascular Drugs Global Market to 2030 - Identify Growth Segments for Investment
17. Mai 2021 04:38 ET
|
Research and Markets
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Cardiovascular Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...